Sandu Pharmaceuticals (524703.BO) Stock Price
Sandu Pharmaceuticals Price
Over the last 12 years Sandu Pharmaceuticals grew revenue by 5.7% annually, reaching 699.35 M INR. Earnings per share have grown at 11.2% per year over the last 12 years. For Sandu Pharmaceuticals, the net margin of 2.5% is broadly stable versus 2.4% a few years ago. At today's price the dividend yield works out to roughly 2.17%. The payout ratio is around 50% of earnings. The dividend has grown at 9.9% per year over the past 5 years.
Sandu Pharmaceuticals stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Sandu Pharmaceuticals business model & stock analysis
Frequently asked questions about Sandu Pharmaceuticals
Converted at the current exchange rate, the Sandu Pharmaceuticals share trades at 0.35 EUR (36.83 INR).
The revenue of Sandu Pharmaceuticals is 699.35 M INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Sandu Pharmaceuticals is 17.66 M INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Sandu Pharmaceuticals is currently 20.15. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sandu Pharmaceuticals stock.
The price-to-sales ratio (P/S) of Sandu Pharmaceuticals is currently 0.51. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sandu Pharmaceuticals stock.
The Eulerpool Quality Score for Sandu Pharmaceuticals is 4/10.
The ISIN of Sandu Pharmaceuticals is INE751D01014. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Sandu Pharmaceuticals is 524703.BO. The ticker symbol is used to trade Sandu Pharmaceuticals shares on the stock exchange.
Sandu Pharmaceuticals stock
Sandu Pharmaceuticals Peer Group
Sandu Pharmaceuticals FIGI
All fundamentals and in-depth analysis of Sandu Pharmaceuticals
Our stock analysis for Sandu Pharmaceuticals stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sandu Pharmaceuticals. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.